27 May 2023 : Clinical Research
Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease
Egle AudronyteDOI: 10.12659/MSM.940363
Med Sci Monit 2023; 29:e940363
Table 3 Results of the odor identification test.
| Odor | NC correct responses (%) | MCI-AD correct responses (%) | MD-AD correct responses (%) |
|---|---|---|---|
| Clove,a | 30 (100.00) | 19 (63.33)* | 18 (60.00)* |
| Fish | 29 (96.67) | 28 (93.33) | 20 (66.67)* |
| Orange | 29 (96.67) | 23 (76.67) | 19 (63.33)* |
| Garlicb | 29 (96.67) | 22 (73.33) | 17 (56.67)* |
| Coffee | 28 (93.33) | 24 (80.00) | 19 (63.33)* |
| Cinnamonb | 28 (93.33) | 19 (63.33)* | 10 (33.33)* |
| Peppermint | 27 (90.00) | 24 (80.00) | 16 (53.33)* |
| Rose | 27 (90.00) | 22 (73.33) | 15 (50.00)* |
| Bananab | 26 (86.67) | 16 (53.33)* | 7 (23.33)* |
| Anis | 25 (83.33) | 19 (63.33) | 17 (56.67) |
| Turpentine | 22 (73.33) | 12 (40.00) | 16 (53.33) |
| NC – normal cognition; AD – Alzheimer disease; MCI-AD – mild cognitive impairment due to Alzheimer disease; MD-AD – mild dementia due to Alzheimer disease. * Significantly different from the NC group 0.016). a The odor that differed the most ( b The odors that differed the most ( | |||






